4 months ago
APLS
AnalystsAnupam RamaAnupam Rama's Stock Forecasts
AnalystsAnupam Rama
Sectors:
Analyst Ranking
Bottom 3%
#4300 out of 4414 analysts
Average Return
-7.56%
Win Rate
44%49 out of 111
Risk vs Reward
Poor
Good
Anupam Rama's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bridgebio Pharma IncBBIO | +207.57% | $9.51 | $29.25 | 2022-11-17 - 2023-11-17 | Strong Buy |
G1 Therapeutics IncGTHX | +129.24% | $17.99 | $41.24 | 2017-06-11 - 2018-06-12 | Strong Buy |
Sarepta Therapeutics IncSRPT | +115.98% | $63.22 | $136.54 | 2018-02-20 - 2019-02-21 | Strong Buy |
Vera Therapeutics IncVERA | +114.29% | $6.23 | $13.35 | 2023-04-11 - 2023-11-29 | Strong Buy |
Mirati Therapeutics IncMRTX | +100.72% | $82.81 | $166.22 | 2020-04-30 - 2021-04-30 | Strong Buy |
Anupam Rama Analyst Color
Get additional color on Anupam Rama's coverage of popular stocks
Anupam Rama's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 8 | Strong Buy | $115.00 | +43.03% | Maintains | a month ago |
Zai Lab LtdZLAB | 7 | Strong Buy | $64.00 | +136.16% | Maintains | a month ago |
Syndax Pharmaceuticals IncSNDX | 4 | Strong Buy | $38.00 | +133.13% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Buy | $81.00 | +61.03% | Upgrades | 2 months ago |
Nuvalent IncNUVL | 3 | Strong Buy | $68.00 | +9.32% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 3 | Strong Buy | $19.00 | +76.58% | Maintains | 2 months ago |
Olema Pharmaceuticals IncOLMA | 2 | Strong Buy | $19.00 | +44.16% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 9 | Strong Buy | $134.00 | +18.02% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $38.00 | +33.47% | Maintains | 3 months ago |
Ideaya Biosciences IncIDYA | 2 | Strong Buy | $32.00 | +2.66% | Maintains | 3 months ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $32.00 | +113.05% | Maintains | 3 months ago |
Generation Bio CoGBIO | 2 | Hold | $9.00 | +675.86% | Maintains | 3 months ago |
Rallybio CorpRLYB | 2 | Strong Buy | $18.00 | +818.37% | Maintains | 4 months ago |
Travere Therapeutics IncTVTX | 1 | Strong Buy | $26.00 | +306.89% | Initiates Coverage On | 4 months ago |
Replimune Group IncREPL | 2 | Strong Buy | $50.00 | +341.70% | Maintains | 5 months ago |
Annexon IncANNX | 1 | Hold | $9.00 | +246.15% | Downgrades | 6 months ago |
Anaptysbio IncANAB | 4 | Hold | $30.00 | +113.07% | Upgrades | 6 months ago |
Vera Therapeutics IncVERA | 3 | Strong Buy | $22.00 | +64.79% | Maintains | 8 months ago |
Kodiak Sciences IncKOD | 5 | Hold | $10.00 | +301.61% | Maintains | 8 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $15.00 | +95.44% | Maintains | 8 months ago |
Kiniksa Pharmaceuticals LtdKNSA | 1 | Strong Buy | $20.00 | +26.42% | Maintains | 9 months ago |
Springworks Therapeutics IncSWTX | 2 | Strong Buy | $57.00 | +112.45% | Maintains | 9 months ago |
G1 Therapeutics IncGTHX | 7 | Hold | $10.00 | +488.24% | Upgrades | 10 months ago |
Sage Therapeutics IncSAGE | 1 | Strong Buy | $60.00 | +208.01% | Maintains | a year ago |
Elevation Oncology IncELEV | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Solid Biosciences IncSLDB | 2 | Hold | N/A | N/A | Upgrades | a year ago |
Mirati Therapeutics IncMRTX | 3 | Strong Buy | $94.00 | N/A | Maintains | a year ago |
Atara Biotherapeutics IncATRA | 5 | Hold | $10.00 | N/A | Downgrades | a year ago |
Passage Bio IncPASG | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Theravance Biopharma IncTBPH | 1 | Hold | $12.00 | N/A | Upgrades | 2 years ago |
Vir Biotechnology IncVIR | 5 | Hold | $37.00 | N/A | Upgrades | 2 years ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $55.00 | N/A | Upgrades | 2 years ago |
Chemocentryx IncCCXI | 3 | Hold | $38.00 | N/A | Upgrades | 2 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $6.00 | N/A | Upgrades | 2 years ago |
Cyteir Therapeutics IncCYT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $54.00 | N/A | Downgrades | 3 years ago |
Korro Bio IncKRRO | 3 | Strong Buy | $56.00 | N/A | Upgrades | 3 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 3 years ago |
Allovir IncALVR | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $137.00 | N/A | Downgrades | 4 years ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | 4 years ago |
Dova Pharmaceuticals IncDOVA | 2 | Strong Sell | $20.00 | N/A | Downgrades | 5 years ago |
La Jolla Pharmaceutical CoLJPC | 4 | Hold | $9.00 | N/A | Upgrades | 5 years ago |
Myokardia IncMYOK | 2 | Strong Buy | $81.00 | N/A | Maintains | 5 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Strong Buy | $188.00 | N/A | Maintains | 5 years ago |
Otonomy IncOTIC | 3 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Clearside Biomedical IncCLSD | 2 | Strong Buy | $18.00 | N/A | Maintains | 6 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Ptc Therapeutics IncPTCT | 2 | Hold | N/A | N/A | Upgrades | 6 years ago |
Prometheus Biosciences IncRXDX | 1 | Strong Buy | $20.00 | N/A | Maintains | 6 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.